Giovanni Fucà

4.6k total citations
87 papers, 1.8k citations indexed

About

Giovanni Fucà is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Giovanni Fucà has authored 87 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Oncology, 36 papers in Pulmonary and Respiratory Medicine and 19 papers in Molecular Biology. Recurrent topics in Giovanni Fucà's work include Cancer Immunotherapy and Biomarkers (19 papers), Cancer Genomics and Diagnostics (12 papers) and Colorectal Cancer Treatments and Studies (12 papers). Giovanni Fucà is often cited by papers focused on Cancer Immunotherapy and Biomarkers (19 papers), Cancer Genomics and Diagnostics (12 papers) and Colorectal Cancer Treatments and Studies (12 papers). Giovanni Fucà collaborates with scholars based in Italy, United States and United Kingdom. Giovanni Fucà's co-authors include Filippo de Braud, Gianpietro Dotti, Barbara Savoldo, Elisa Landoni, Claudio Vernieri, Massimo Di Nicola, Loïc Reppel, Filippo Pietrantonio, Peishun Shou and Giulia Galli and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Giovanni Fucà

84 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giovanni Fucà Italy	23	1.2k	549	382	293	204	87	1.8k
Audrey Mansuet‐Lupo France	22	981 0.9×	722 1.3×	462 1.2×	326 1.1×	321 1.6×	64	1.8k
Andrew Dean Australia	17	1.1k 1.0×	694 1.3×	262 0.7×	124 0.4×	267 1.3×	104	1.6k
Sophie Cousin France	21	1.2k 1.0×	862 1.6×	320 0.8×	450 1.5×	181 0.9×	126	1.9k
Hiroshige Nakamura Japan	24	539 0.5×	805 1.5×	407 1.1×	405 1.4×	220 1.1×	166	2.0k
Susan M. Hiniker United States	20	702 0.6×	627 1.1×	383 1.0×	266 0.9×	181 0.9×	108	1.6k
Yusri Elsayed United States	22	1.1k 1.0×	606 1.1×	1.1k 2.8×	422 1.4×	208 1.0×	51	2.4k
Tai Hato Japan	16	822 0.7×	342 0.6×	435 1.1×	522 1.8×	379 1.9×	38	1.8k
Halla Nimeiri United States	26	1.2k 1.0×	386 0.7×	311 0.8×	132 0.5×	239 1.2×	84	1.8k
Yungan Tao France	27	1.0k 0.9×	660 1.2×	586 1.5×	163 0.6×	248 1.2×	112	2.3k
H Arnholdt Germany	23	943 0.8×	637 1.2×	338 0.9×	133 0.5×	384 1.9×	75	2.0k

Countries citing papers authored by Giovanni Fucà

Since Specialization

Citations

This map shows the geographic impact of Giovanni Fucà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanni Fucà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanni Fucà more than expected).

Fields of papers citing papers by Giovanni Fucà

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanni Fucà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanni Fucà. The network helps show where Giovanni Fucà may publish in the future.

Co-authorship network of co-authors of Giovanni Fucà

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanni Fucà. A scholar is included among the top collaborators of Giovanni Fucà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanni Fucà. Giovanni Fucà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rivoltini, Licia, Chiara Camisaschi, Giovanni Fucà, et al.. (2024). Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade. Scientific Reports. 14(1). 3379–3379. 6 indexed citations

Fucà, Giovanni, Alessandra Raimondi, Michele Prisciandaro, et al.. (2022). Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study. The Oncologist. 27(1). e29–e36. 5 indexed citations

Landoni, Elisa, Giovanni Fucà, Jian Wang, et al.. (2021). Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic Signaling. Cancer Immunology Research. 9(4). 441–453. 56 indexed citations

Randon, Giovanni, Rossana Intini, Chiara Cremolini, et al.. (2021). Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer. European Journal of Cancer. 161. 90–98. 15 indexed citations

Corti, Francesca, Sara Lonardi, Rossana Intini, et al.. (2021). The Pan-Immune-Inflammation Value in microsatellite instability–high metastatic colorectal cancer patients treated with immune checkpoint inhibitors. European Journal of Cancer. 150. 155–167. 78 indexed citations

Fabbroni, Chiara, Giovanni Fucà, Francesca Ligorio, et al.. (2021). Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin. Cancers. 13(6). 1453–1453. 14 indexed citations

Santis, Francesca De, Giovanni Fucà, Dirk Schadendorf, et al.. (2021). Anticancer innovative therapy congress: Highlights from the 10th anniversary edition. Cytokine & Growth Factor Reviews. 59. 1–8. 3 indexed citations

Mainini, Francesco, Francesca De Santis, Giovanni Fucà, et al.. (2021). Nanobiotechnology and Immunotherapy: Two Powerful and Cooperative Allies against Cancer. Cancers. 13(15). 3765–3765. 8 indexed citations

Sanfilippo, Roberta, Chiara Fabbroni, Giovanni Fucà, et al.. (2020). Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors. Clinical Cancer Research. 26(20). 5534–5538. 18 indexed citations

10.

Landoni, Elisa, Christof C. Smith, Giovanni Fucà, et al.. (2019). A High-Avidity T-cell Receptor Redirects Natural Killer T-cell Specificity and Outcompetes the Endogenous Invariant T-cell Receptor. Cancer Immunology Research. 8(1). 57–69. 12 indexed citations

11.

Sanfilippo, Roberta, Robin L. Jones, Jean‐Yves Blay, et al.. (2019). Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas). Clinical Cancer Research. 25(17). 5295–5300. 75 indexed citations

12.

Galli, Giulia, Tiziana Triulzi, Claudia Proto, et al.. (2019). Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer. Lung Cancer. 132. 72–78. 53 indexed citations

13.

Fucà, Giovanni, Nadia Hindi, Isabelle Ray‐Coquard, et al.. (2018). Treatment Outcomes and Sensitivity to Hormone Therapy of Aggressive Angiomyxoma: A Multicenter, International, Retrospective Study. The Oncologist. 24(7). e536–e541. 26 indexed citations

14.

Sanfilippo, Roberta, Elena Fumagalli, Paola Collini, et al.. (2018). Impact of pathological stratification of advanced well differentiated/dedifferentiated (WD/DD) liposarcoma (LPS) on the response to trabectedin (T).. Journal of Clinical Oncology. 36(15_suppl). 11566–11566.

15.

Maltese, Giuseppa, Caterina Fontanella, Cono Scaffa, et al.. (2017). Atypical Uterine Smooth Muscle Tumors: A Retrospective Evaluation of Clinical and Pathologic Features. Oncology. 94(1). 1–6. 8 indexed citations

16.

Schwartz, Sarit, Franco Cecchi, Yuan Tian, et al.. (2017). Selecting patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of MGMT. Annals of Oncology. 28. iii95–iii95. 3 indexed citations

17.

Bogani, Giorgio, Ilaria Sabatucci, Giuseppa Maltese, et al.. (2016). Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology. 208. 41–45. 13 indexed citations

18.

Bogani, Giorgio, Giovanni Fucà, Giuseppa Maltese, et al.. (2016). Efficacy of adjuvant chemotherapy in early stage uterine leiomyosarcoma: A systematic review and meta-analysis. Gynecologic Oncology. 143(2). 443–447. 41 indexed citations

19.

Raspagliesi, Francesco, Giuseppa Maltese, Giorgio Bogani, et al.. (2016). Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study. Gynecologic Oncology. 144(1). 90–95. 60 indexed citations

20.

Cavalieri, Stefano, Alessandra Raimondi, Daniele Morelli, et al.. (2016). Pro-gastrin releasing peptide (pro-GRP) in small cell lung cancer staging. Annals of Oncology. 27. iv13–iv13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact